8
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A case of primary aldosteronism with secondary hyperparathyroidism and bilateral adrenal tumors

      research-article
      ,
      Endocrinology, Diabetes & Metabolism Case Reports
      Bioscientifica Ltd
      Adult, Female, Asian - Japanese, Japan, Adrenal, Adrenal, Aldosterone, Mineralocorticoids, PTH, Hyperaldosteronism, Conn's syndrome, Hyperparathyroidism (secondary), Adrenocortical adenoma, Myasthenia, Hypertension, Potassium, Calcium (serum), PTH, TRAP 5b, C1NP, Aldosterone to renin ratio, Aldosterone (24-hour urine), CT scan, Cortisol (serum), ACTH stimulation, Immunohistochemistry, Bone mineral density test, Dexamethasone suppression (low dose), Aldosterone (plasma), Adrenalectomy, Potassium chloride, Radiology/Rheumatology, Surgery, Urology, Unique/unexpected symptoms or presentations of a disease, July, 2015

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          A 43-year-old Japanese woman was admitted to our hospital with weakness. Laboratory findings showed hypokalemia, hypocalcemia and elevation of the serum creatinine phosphokinase levels, but intact parathyroid hormone levels. Further evaluations suggested that she had primary aldosteronism (PA), secondary hyperparathyroidism and bilateral adrenal tumors. She was treated successfully by laparoscopic right adrenalectomy. This case not only serves to the diagnosis of bilateral adrenal tumors in which selective adrenal venous sampling (SAVS) proved to be useful, but also for physicians to be aware of secondary hyperparathyroidism and the risk of secondary osteoporosis caused by PA.

          Learning points

          • The classic presenting signs of PA are hypertension and hypokalemia.

          • Hypokalemia can induce rhabdomyolysis.

          • PA causes secondary hyperparathyroidism.

          • Patients with PA have the risk of osteoporosis with secondary hyperparathyroidism.

          • SAVS is useful in bilateral adrenal tumors.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.

          Inappropriate aldosterone and parathyroid hormone (PTH) secretion is strongly linked with development and progression of cardiovascular (CV) disease. Accumulating evidence suggests a bidirectional interplay between parathyroid hormone and aldosterone. This interaction may lead to a disproportionally increased risk of CV damage, metabolic and bone diseases. This review focuses on mechanisms underlying the mutual interplay between aldosterone and PTH as well as their potential impact on CV, metabolic and bone health. PTH stimulates aldosterone secretion by increasing the calcium concentration in the cells of the adrenal zona glomerulosa as a result of binding to the PTH/PTH-rP receptor and indirectly by potentiating angiotensin 2 induced effects. This may explain why after parathyroidectomy lower aldosterone levels are seen in parallel with improved cardiovascular outcomes. Aldosterone mediated effects are inappropriately pronounced in conditions such as chronic heart failure, excess dietary salt intake (relative aldosterone excess) and primary aldosteronism. PTH is increased as a result of (1) the MR (mineralocorticoid receptor) mediated calciuretic and magnesiuretic effects with a trend of hypocalcemia and hypomagnesemia; the resulting secondary hyperparathyroidism causes myocardial fibrosis and disturbed bone metabolism; and (2) direct effects of aldosterone on parathyroid cells via binding to the MR. This adverse sequence is interrupted by mineralocorticoid receptor blockade and adrenalectomy. Hyperaldosteronism due to klotho deficiency results in vascular calcification, which can be mitigated by spironolactone treatment. In view of the documented reciprocal interaction between aldosterone and PTH as well as the potentially ensuing target organ damage, studies are needed to evaluate diagnostic and therapeutic strategies to address this increasingly recognized pathophysiological phenomenon.
            • Record: found
            • Abstract: found
            • Article: not found

            Adrenocortical zonation in humans under normal and pathological conditions.

            Aldosterone synthase (CYP11B2) and steroid 11 beta-hydroxylase (CYP11B1) catalyze the terminal steps for aldosterone and cortisol syntheses, respectively, thereby determining the functional differentiation of human adrenocortical cells. Little is known, however, about how the cells expressing the enzymes are actually distributed in the adrenals under normal and pathological conditions. The objective of the study was to determine the localization of CYP11B2 and -B1 in human adrenal specimens by using developed antibodies capable of distinguishing the two enzymes from each other. Under normal conditions, CYP11B2 was sporadically detected in the zona glomerulosa, whereas CYP11B1 was entirely detected in the zonae fasciculata-reticularis. Adrenocortical cells lacking both enzymes were observed in the outer cortical regions. In addition to conventional zonation, we found a variegated zonation consisting of a subcapsular cell cluster expressing CYP11B2, which we termed aldosterone-producing cell cluster, and a CYP11B1-expressing area. Aldosterone-producing adenomas differed in cell populations expressing CYP11B2 from one another, whereas CYP11B1-expressing and double-negative cells were also intermingled. Adenomas from patients with Cushing's syndrome expressed CYP11B1 entirely but not CYP11B2, resulting in atrophic nontumor glands. The nontumor portions of both types of adenomas bore frequently one or more aldosterone-producing cell clusters, which sustained CYP11B2 expression markedly under the conditions of the suppressed renin-angiotensin system. Immunohistochemistry of the human normal adrenal cortex for CYP11B2 and CYP11B1 revealed a variegated zonation with cell clusters constitutively expressing CYP11B2. This technique may provide a pathological confirmatory diagnosis of adrenocortical adenomas.
              • Record: found
              • Abstract: found
              • Article: not found

              Bone health and aldosterone excess.

              A picture of hyperparathyroidism secondary to increased urinary calcium excretion was found in 116 patients with primary aldosteronism (PA), compared with 110 essential hypertensives. After medical or surgical treatment in 40 PA patients, parathyroid hormone (PTH) levels were significantly reduced and bone mineral density (BMD) significantly increased at the lumbar spine, femoral neck, and total hip.

                Author and article information

                Contributors
                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                01 August 2015
                01 August 2015
                : 2015
                : 15-0029
                Affiliations
                [1 ] Department of Internal Medicine , Uwajima City Hospital , 1-1 Gotenmachi, Uwajima, Ehime, 798-8510, Japan
                Article
                EDM150029
                10.1530/EDM-15-0029
                8142324
                30367749
                2828883b-a68c-4863-b031-66b74a5bb396
                © 2015 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License.

                History
                : 28 May 2015
                : 19 June 2015
                Categories
                Adult
                Female
                Asian - Japanese
                Japan
                Adrenal
                Adrenal
                Aldosterone
                Mineralocorticoids
                PTH
                Hyperaldosteronism
                Conn's Syndrome
                Hyperparathyroidism (Secondary)
                Adrenocortical Adenoma
                Hypertension
                Potassium
                Calcium (serum)
                PTH
                TRAP 5b
                C1NP
                Aldosterone to renin ratio
                Aldosterone (24-hour urine)
                CT scan
                Cortisol (serum)
                ACTH stimulation
                Immunohistochemistry
                Bone mineral density test
                Dexamethasone suppression (low dose)
                Aldosterone (plasma)
                Adrenalectomy
                Potassium chloride
                Radiology/Rheumatology
                Surgery
                Urology
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,female,asian - japanese,japan,adrenal,aldosterone,mineralocorticoids,pth,hyperaldosteronism,conn's syndrome,hyperparathyroidism (secondary),adrenocortical adenoma,myasthenia,hypertension,potassium,calcium (serum),trap 5b,c1np,aldosterone to renin ratio,aldosterone (24-hour urine),ct scan,cortisol (serum),acth stimulation,immunohistochemistry,bone mineral density test,dexamethasone suppression (low dose),aldosterone (plasma),adrenalectomy,potassium chloride,radiology/rheumatology,surgery,urology,unique/unexpected symptoms or presentations of a disease,july,2015

                Comments

                Comment on this article

                Related Documents Log